Category
Drug Product CDMOs
Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
About Drug Product Manufacturing
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Companies (1365)
Cleo Singapore
Singapore
Cleo Singapore Pte Ltd, founded in 1993, is a global supplier and distributor of Active Pharmaceutical Ingredients (APIs) for human, veterinary, and personal care use, as well as pharmaceutical finished formulations. The company operates as a sourcing and distribution partner, connecting manufacturers with markets, and also handles regulatory submissions, but does not operate its own drug manufacturing facilities.
Cognanous
United States
Cognanous (doing business as Cognano) is a US-based biotech company that leverages alpaca and shark antibody data combined with AI/LLM technology to discover novel biomarkers for drug discovery. The company developed IBMET (Inverse Biomarker Exploring Technology) to identify novel antigens and therapeutic candidates, focusing on biomarker discovery rather than contract manufacturing or drug development services.
Comar
Ireland
Comar is a contract manufacturer of plastic packaging and medical device components for the healthcare industry. The company provides injection molding, injection blow molding, extrusion blow molding, and injection stretch blow molding technologies for primary packaging and drug delivery device components. Comar operates multiple manufacturing and engineering facilities across the United States and Ireland, serving pharmaceutical, nutraceutical, and medical device markets.
Frequently Asked Questions
What is drug product manufacturing?+
Drug product manufacturing converts APIs into final dosage forms for patients. The process includes formulation development (choosing excipients, optimizing bioavailability), process development (granulation, compression, coating, filling), analytical method development, stability testing, and scale-up to commercial volumes. It also covers packaging and labeling.
What dosage forms can drug product CDMOs produce?+
Common dosage forms include tablets (immediate-release, modified-release, orally disintegrating), capsules (hard gelatin, HPMC, softgel), sterile injectables (lyophilized, liquid), semi-solids (creams, ointments, gels), liquids (solutions, suspensions, syrups), and specialty forms (transdermal patches, inhalers, suppositories, implants). Most CDMOs specialize in 2-3 dosage forms rather than offering all.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
